CS59492A3 - Canglemycin c, process of its preparation, its use, a pharmaceutical and astrain for said canglemycin c preparation - Google Patents

Canglemycin c, process of its preparation, its use, a pharmaceutical and astrain for said canglemycin c preparation Download PDF

Info

Publication number
CS59492A3
CS59492A3 CS92594A CS59492A CS59492A3 CS 59492 A3 CS59492 A3 CS 59492A3 CS 92594 A CS92594 A CS 92594A CS 59492 A CS59492 A CS 59492A CS 59492 A3 CS59492 A3 CS 59492A3
Authority
CS
Czechoslovakia
Prior art keywords
kanglemycin
physiologically active
active substance
pharmaceutically acceptable
preparation
Prior art date
Application number
CS92594A
Other languages
Czech (cs)
English (en)
Inventor
Wang Nanjin
Yang Xianshu
Original Assignee
Nippon Kayaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Kk filed Critical Nippon Kayaku Kk
Publication of CS59492A3 publication Critical patent/CS59492A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CS92594A 1991-03-01 1992-02-28 Canglemycin c, process of its preparation, its use, a pharmaceutical and astrain for said canglemycin c preparation CS59492A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN91101127A CN1037526C (zh) 1991-03-01 1991-03-01 康乐霉素c的生产方法

Publications (1)

Publication Number Publication Date
CS59492A3 true CS59492A3 (en) 1992-09-16

Family

ID=4904964

Family Applications (1)

Application Number Title Priority Date Filing Date
CS92594A CS59492A3 (en) 1991-03-01 1992-02-28 Canglemycin c, process of its preparation, its use, a pharmaceutical and astrain for said canglemycin c preparation

Country Status (10)

Country Link
US (1) US5275817A (zh)
EP (1) EP0501399A1 (zh)
JP (1) JPH0570470A (zh)
KR (1) KR920018226A (zh)
CN (1) CN1037526C (zh)
AU (1) AU1119892A (zh)
CA (1) CA2061642A1 (zh)
CS (1) CS59492A3 (zh)
HU (1) HUT63883A (zh)
IL (1) IL101103A0 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002367A1 (fr) * 2002-06-27 2004-01-08 Microport Medical (Shanghai) Co., Ltd. Stent eluant des medicaments
US6908484B2 (en) 2003-03-06 2005-06-21 Spinecore, Inc. Cervical disc replacement

Also Published As

Publication number Publication date
CN1064504A (zh) 1992-09-16
HUT63883A (en) 1993-10-28
CN1037526C (zh) 1998-02-25
IL101103A0 (en) 1992-11-15
EP0501399A1 (en) 1992-09-02
HU9200677D0 (en) 1992-05-28
AU1119892A (en) 1992-09-03
KR920018226A (ko) 1992-10-21
US5275817A (en) 1994-01-04
JPH0570470A (ja) 1993-03-23
CA2061642A1 (en) 1992-09-02

Similar Documents

Publication Publication Date Title
JP3140228B2 (ja) 新規な大環状ラクトンおよびその生産菌
EP1751272B1 (en) Production of tacrolimus (fk-506) using new streptomyces species
MXPA97003484A (en) Macrocyclic lactone compounds and their product procedure
EP1211259B1 (en) Antibiotic caprazamycins and process for producing the same
FR2568892A1 (fr) Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine
KR840001258B1 (ko) 신항생물질 mf 266 물질의 제조방법
CS59492A3 (en) Canglemycin c, process of its preparation, its use, a pharmaceutical and astrain for said canglemycin c preparation
US6852715B1 (en) Indolocarbazole alkaloids from a marine actinomycete
US5002959A (en) BU-4146T antibiotic
CA1263621A (en) Fr-900848 substance and preparation thereof
EP0818464A1 (en) Methylsulfomycin l, a process for its production and its use
US20130130992A1 (en) Dipeptide derivative for the treatment of cancer
EP1324980B1 (en) Citrullimycines, a process for their production and their use as pharmaceuticals
CA2020878C (en) Antitumor antibiotic bu-3285t
JP2989674B2 (ja) 制癌性物質サイトブラスチンおよびその製造法
EP0205308B1 (en) Scytophycins
ITMI950865A1 (it) Derivati della purporogallina
JPS6332437B2 (zh)
KR860001215B1 (ko) 안지오텐신-전환 효소 억제제의 제조방법
JPH03255082A (ja) 新規抗生物質rk―441s、その製造法、抗腫瘍剤並びに免疫抑制剤
JP2000178244A (ja) 免疫抑制物質ic202a,bおよびc物質とその製造法
FR2550536A1 (fr) Desacetyl-ravidomycine, son procede de production et son application en therapeutique
JPH06228185A (ja) D329物質とその誘導体,その製造法及び用途
JPH05155885A (ja) 新規hp530c2 物質及びその製造法
WO2004046368A1 (ja) 新規抗生物質ムラミノミシン(Muraminomicin)